COMMUNIQUÉS West-GlobeNewswire

Virbac : Mise à disposition de l'information financière trimestrielle au 30 septembre 2018
14/11/2018
Virbac : Mise à disposition de l'information financière trimestrielle au 30 septembre 2018 Communiqué diffusé le 14 novembre 2018 L'information financière trimestrielle au 30 septembre 2018 est disponible : · sur notre [...]
Genmab Announces Financial Results for the First Nine Months of 2018
14/11/2018
November 14, 2018; Copenhagen, Denmark; Interim Report for the First Nine Months Ended September 30, 2018 Highlights USD 1,441 million in net sales of DARZALEX ® (daratumumab), resulting in royalty income of DKK 1,111 [...]
On Transactions Under Regulation No 596/2014
14/11/2018
Additional information available in the document attached. Information prepared by: Inga Krukle Member of the Management Board JSC Olainfarm Phone: +371 28698449 E-mail: inga.krukle@olainfarm.com Attachment [...]
On Transactions Under Regulation No 596/2014
14/11/2018
Additional information available in the document attached. Information prepared by: Inga Krukle Member of the Management Board JSC Olainfarm Phone: +371 28698449 E-mail: inga.krukle@olainfarm.com Attachment [...]
Webinar to Highlight Technology Underlying Precipio’s ICE COLD-PCR on November 20, 2018
14/11/2018
Current Status, Existing and Future Applications of COLD-PCR for Cancer and Prenatal Diagnosis to Be Presented NEW HAVEN, Conn., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: [...]
About acquisition of significant shareholding
14/11/2018
On November 12, 2018, JSC Olainfarm received a notification from shareholder OLFIM OÜ on increased shareholding up till 7.79% from share capital with voting rights, since the November 6, 2018. The announcement of OLFIM [...]
Change in significant shareholding
14/11/2018
On November 12, 2018, JSC "Olainfarm" received a notification by shareholder Irina Maligina stating that since November 6, 2018, the form of participation of I.Maligina has changed: from direct to indirect. The notice [...]
Phoenix Life Sciences Receives Import Certificate for Cannabis Diabetes Drug from the Republic of Vanuatu
14/11/2018
DENVER, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTCMarkets: PLSI) (“Phoenix Life”), an international adaptive healthcare solutions company, today announced that it has received an [...]
Nemaura Medical to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
14/11/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by people with diabetes [...]
Diffusion Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
14/11/2018
Highlights Include FDA Approval of Phase 2 On-Ambulance Clinical Trial for Treatment of Stroke and Appointment of New Chief Financial Officer CHARLOTTESVILLE, Va., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Diffusion [...]
Chiesi Salutes Neonatal Intensive Care Unit Staff in Honor of Prematurity Awareness Month®
14/11/2018
In partnership with March of Dimes, video featuring parents of preterm infants and NICU staff raises awareness of prematurity through first-hand accounts from the NICU CARY, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) -- In [...]
Mateon Therapeutics Reports Third Quarter 2018 Financial Results
14/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology indications, today [...]
Virginia Premier Expands Engagement With the Inovalon One® Platform
14/11/2018
Leading Health Plan Expands Use of Inovalon Platform to Add Automated Clinical Data Extraction and Natural Language Processing Toolsets BOWIE, Md., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading [...]
Teladoc Health, USC Collaborate for Groundbreaking Study of Virtual Care Prescribing
14/11/2018
Researchers take telehealth quality initiatives to the next level by examining antibiotic prescribing influences PURCHASE, NY, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual [...]
Advanced Proteome Therapeutics Reports Positive Results and Advances Collaboration with Heidelberg Pharma
14/11/2018
VANCOUVER, British Columbia , Nov. 14, 2018 (GLOBE NEWSWIRE) -- Advanced Proteome Therapeutics Corporation (“APC” or the “Company”) (TSXV: APC) (FSE: 0E8) , is pleased to announce very positive results from animal [...]
Ultragenyx Announces Intent to Submit New Drug Application to U.S. FDA for UX007 for the Treatment of Long-chain Fatty Acid Oxidation Disorders in Mid-2019
14/11/2018
NOVATO, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Helomics Corp Partners with UK 100,000 Genomes Project to Drive its Artificial Intelligence-Powered Precision Oncology Platform for Ovarian Cancer
14/11/2018
Helomics will utilize whole genome and outcome data from the U.K. 100,000 Genomes Project to advance its artificial intelligence-based platform for ovarian cancer. PITTSBURGH and LONDON, Nov. 14, 2018 (GLOBE NEWSWIRE [...]
Veritas Announces Binding Share Purchase Agreement with Leis Industries Limited for Sale of Sechelt Organic Marijuana
14/11/2018
VANCOUVER, British Columbia, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that it has entered into a binding [...]
Introducing Veradigm™ Providing Next Generation Healthcare Solutions for Today’s Healthcare Challenges
14/11/2018
Data-driven insight and solutions CHICAGO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ: MDRX) announced Veradigm as the new branding for Allscripts’ Payer & Life Sciences division. Veradigm is a [...]

Pages